InvestorsHub Logo
Followers 1869
Posts 82136
Boards Moderated 2
Alias Born 10/08/2009

Re: None

Wednesday, 11/22/2017 11:43:43 AM

Wednesday, November 22, 2017 11:43:43 AM

Post# of 19565
here is your big money sentence: HIV Vaccine Trials Network (HVTN) has closed enrollment for the phase 1 human clinical trial evaluating late boosts of GeoVax's preventive vaccine (GOVX-B11) for clade B HIV. The trial, designated HVTN 114, is being conducted by the HVTN and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH

Wowzastock's members board:
http://investorshub.advfn.com/boards/board.aspx?board_id=20042

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GOVX News